by KJ McElrath | Aug 22, 2016 | Invokana |
Initially hailed as a “miracle drug” in the treatment of Type 2 diabetes, Invokana is part of a...
by Martin Levin | May 31, 2016 | Invokana |
Considering our government is bought and paid for by Big Pharma, it’s only fitting that Janssen...
by Mike Papantonio | Feb 27, 2016 | Invokana |
A blockbuster diabetes drug called Invokana has pulled in hundreds of millions of dollars for Big...
by KJ McElrath | Oct 24, 2015 | Invokana |
In addition to kidney damage, ketoacidosis and heart attacks, it turns out that canagliflozin –...
by KJ McElrath | Aug 11, 2015 | Invokana |
According to data from the U.S. Centers for Medicare and Medicaid, in 2014 Johnson & Johnson...
